COMPANY PROFILE

PreciThera

Explore full profile

Biological therapeutics for the treatment of orphan bone diseases

Montreal, CanadaFounded 2016Biotech & Life Sciences

Valuation $100–250M Last recorded · 2017

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About PreciThera

Precithera is a biotechnology company focused on developing precision therapies for oncology and rare diseases. The company operates in the biopharmaceutical market, targeting unmet medical needs with innovative treatments. Precithera's business model involves extensive research and development to create targeted therapies that offer significant clinical benefits. Revenue is generated through partnerships, licensing agreements, and the commercialization of proprietary treatments. The company serves healthcare providers, patients, and pharmaceutical partners, aiming to improve patient outcomes and quality of life.

MoreLess Source: Dealroom company data

At a glance

Status: Closed
Founded: 2016
Headquarters: Montreal, Canada
Employees: 2
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jul 2017	$29M	$116M	CTI Life Sciences · Sanderling Ventures · Fonds de solidarité FTQ · Arix Bioscience	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

PreciThera website traffic

Latest recorded traffic for PreciThera is 0 monthly website visits. PreciThera's team declined 50% over the past year.

Latest monthly visits0 1-year team growth-50%

Monthly website visitsJan 2017–Oct 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HLHeranova LifesciencesA Boston-based biotech company solely focused on developing integrated care solutions for women's health issues	Burlington, United States	Operational	21	$24M	$54M
VBVega BioImagingOffering plasmonic nanoparticles , typically from gold and silver alloys, applied as optical markers for biochemical or biomedical diagnostics	Montreal, Canada	Operational
ATAtG TherapeuticsAt AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance	L'Hospitalet de Llobregat, Spain	Operational
BPBio PaletteBio Palette aims to become a world-leading company in the field of microbiome therapeutics by using bacteria optimized by genome editing to modify and control microbiomes	Kobe, Japan	Operational
IAImmunito AIAn in-silico Antibody Discovery company which uses Artificial Intelligence to give the fastest and most accurate solutions	Bengaluru, India	Operational
SISideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers	Paris, France	Closed
KTKintsugi TherapeuticsDevelopment of ER stress inhibitors for the treatment of metabolic diseases	Barcelona, Spain	Operational
ASASYLIACompanion Diagnostics For Immunotherapy \| Asylia Diagnostics	Beerse, Belgium	Operational